Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

In response to Dr. Yang and colleagues.

Huang WY, Su YF, Lin KT, Lin JC, Chang YW, Fan CY.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1592; author reply 1592. doi: 10.1016/j.ijrobp.2011.04.056. No abstract available.

PMID:
22115559
2.

Clinical implications of the tumor volume reduction rate in head-and-neck cancer during definitive intensity-modulated radiotherapy for organ preservation.

Yang SN, Liao CY, Chen SW, Liang JA, Tsai MH, Hua CH, Lin FJ.

Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1096-103. doi: 10.1016/j.ijrobp.2009.12.055. Epub 2010 Jun 3.

PMID:
20605362
3.

Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma.

Mendenhall WM, Amdur RJ, Morris CG, Kirwan JM, Li JG.

Laryngoscope. 2010 Nov;120(11):2218-22. doi: 10.1002/lary.21144.

PMID:
20938964
4.

Prospective assessment of patterns of failure after high-precision definitive (chemo)radiation in head-and-neck squamous cell carcinoma.

Gupta T, Jain S, Agarwal JP, Ghosh-Laskar S, Phurailatpam R, Pai-Shetty R, Dinshaw KA.

Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):522-31. doi: 10.1016/j.ijrobp.2010.01.054. Epub 2010 Jun 18.

PMID:
20646862
5.

Outcomes of postoperative simultaneous modulated accelerated radiotherapy for head-and-neck squamous cell carcinoma.

Moon SH, Jung YS, Ryu JS, Choi SW, Park JY, Yun T, Lee SH, Cho KH.

Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):140-9. doi: 10.1016/j.ijrobp.2010.04.068. Epub 2010 Aug 21.

PMID:
20732767
6.

RapidArc planning and delivery in patients with locally advanced head-and-neck cancer undergoing chemoradiotherapy.

Doornaert P, Verbakel WF, Bieker M, Slotman BJ, Senan S.

Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):429-35. doi: 10.1016/j.ijrobp.2009.11.014. Epub 2010 Apr 24.

PMID:
20421159
7.

[Salvage surgery for radiation failure in oral, oropharyngeal, and hypopharyngeal squamous cell carcinoma].

Suzuki M, Terada A, Ogawa T, Suzuki H, Hasegawa Y.

Nihon Jibiinkoka Gakkai Kaiho. 2007 Jun;110(6):461-5. Japanese.

PMID:
17633115
8.

Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.

Verbakel WF, Cuijpers JP, Hoffmans D, Bieker M, Slotman BJ, Senan S.

Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):252-9. doi: 10.1016/j.ijrobp.2008.12.033.

PMID:
19362244
9.
10.

Application of the immunohistochemical method as a predictive assay in radiotherapy of squamous cell carcinoma of oropharynx and hypopharynx.

Ogawa Y, Maeda T, Seguchi H, Inomata T, Yoshida S, Kishimoto S, Saito H.

Oncology. 1990;47(2):155-9.

PMID:
2314828
11.
12.

Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx.

Daly ME, Le QT, Jain AK, Maxim PG, Hsu A, Loo BW Jr, Kaplan MJ, Fischbein NJ, Colevas AD, Pinto H, Chang DT.

Head Neck. 2011 Jan;33(1):103-11. doi: 10.1002/hed.21406.

PMID:
20848427
13.

Influence of the delay of adjuvant postoperative radiation therapy on relapse and survival in oropharyngeal and hypopharyngeal cancers.

Bastit L, Blot E, Debourdeau P, Menard J, Bastit P, Le Fur R.

Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):139-46.

PMID:
11163507
14.

Delayed lower cranial neuropathies following primary radiotherapy for oropharyngeal squamous cell carcinoma.

Huang AT, Song S, Dominguez LM, Nguyen J, Goldman RA, Reiter ER.

Laryngoscope. 2013 May;123(5):1207-9. doi: 10.1002/lary.23938.

PMID:
23619622
15.

Concurrent chemoradiotherapy with helical tomotherapy for oropharyngeal cancer: a preliminary result.

Shueng PW, Wu LJ, Chen SY, Hsiao CH, Tien HJ, Cheng PW, Kuo YS, Chen YJ, Chen CA, Hsieh PY, Hsieh CH.

Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):715-21. doi: 10.1016/j.ijrobp.2009.06.026. Epub 2009 Oct 29.

PMID:
19879069
16.

Intensity-modulated radiotherapy: is xerostomia still prevalent?

Chambers MS, Garden AS, Rosenthal D, Ahamad A, Schwartz DL, Blanco AI, Chao KS, Morrison WH, Ang KK, Weber RS.

Curr Oncol Rep. 2005 Mar;7(2):131-6. Review.

PMID:
15717947
17.
18.

Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience.

Shirinian MH, Weber RS, Lippman SM, Dimery IW, Earley CL, Garden AS, Michaelson J, Morrison WH, Kramer A, Byers R, et al.

Head Neck. 1994 Jan-Feb;16(1):39-44.

PMID:
7510276
19.

Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma.

Clavel S, Nguyen DH, Fortin B, Després P, Khaouam N, Donath D, Soulières D, Guertin L, Nguyen-Tan PF.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):582-9. doi: 10.1016/j.ijrobp.2010.10.061. Epub 2011 Feb 1.

PMID:
21277695
20.

Treatment outcomes of locally advanced oropharyngeal cancer: a comparison between combined modality radio-chemotherapy and two variants of single modality altered fractionation radiotherapy.

Kader HA, Mydin AR, Wilson M, Alexander C, Shahi J, Pathak I, Wu JS, Truong PT.

Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1030-6. doi: 10.1016/j.ijrobp.2010.03.048. Epub 2010 Aug 1.

PMID:
20675071

Supplemental Content

Support Center